ClinicalTrialsFinder

Immune Checkpoint Inhibitors (ICIs) Clinical Trials in Guiyang

1 recruitingGuiyang, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

ctDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Non-small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University70 enrolled20 locationsNCT06951646